and a list of the evidence used, as a priority so that this can be evaluated by epilepsy experts. We have also sought an assurance that should category three remain, that drugs are only placed on ...

This list doesn’t include all possible mild ... migraine headaches in clinical trials. People taking the drug to treat epilepsy also reported this side effect, but it was less common.

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...